Healthcare Industry News: Bard
News Release - April 23, 2012
ETView Medical, Ltd. and Champ Medics Co., Ltd. (Champ Medics) Execute Distribution AgreementThe agreement enables Champ Medics to market ETView's VivaSight™ airway management platform in Taiwan.
TEL AVIV, Israel--(Healthcare Sales & Marketing Network)--ETView Medical, Ltd. (TASE: ETVW.TA ) announced today that it has entered into a distribution agreement with Champ Medics Co., Ltd. (Champ Medics). The agreement enables Champ Medics to market ETView's VivaSight™ airway management platform (previously known as TVT™), in Taiwan for a period of 2 years. Other terms were not disclosed.
William Edelman, CEO of ETView Medical, commented, “We are excited to add Champ Medics to our expanding distributor network.” Mr. Edelman continued, “VivaSight™ is currently being distributed across Europe, Asia and the United States. VivaSight™ provides best-in-class airway management solutions for sophisticated thoracic surgical procedures requiring lung isolation.”
On March 19, 2012, ETView announced a distribution agreement with Amphar b.v., a medical device and generic pharmaceutical distributor in the Netherlands.
On March 12, 2012, ETView announced KFDA Pre-Market Clearance for the VivaSight™-SL line of Innovative Airway Devices.
On March 5, 2012 and February 6, 2012, ETView announced filing of a Technical File, initiating CE Registration and a Pre-Marketing Notification Application (510(k)) with the FDA for the Viva™ EB Line of Innovative Endobronchial Blockers.
On February 7, and February 2, 2012, ETView announced distribution agreements with NeuroMed Ltd. (NeuroMed), a surgical products sales and distribution company based in St. Petersburg, Russia, and State of the Art (SOTA) Medical Products, Inc., a specialty surgical products sales and distribution company, based in Cedar Grove, New Jersey.
On December 12, 2011, ETView announced that the company filed a pre-Marketing Notification Application (510(k)) with the FDA for the VIVASIGHT™ DL Airway Management System. VivaSight™-DL1 is a proprietary, single-use disposable medical device, consisting of a dual lumen airway ventilation tube with an integrated continuous high resolution video airway imaging system permitting airway control and lung isolation during certain surgical procedures.
About Champ Medics Ltd.:
According to information provided to the company, Champ Medics Co., Ltd. was founded in 1995. Champ Medics currently markets and distributes medical devices produced by Vitalcor, Aspen Surgical, Fresenius Medical Care, Edwards Lifesciences, Inc. and C.R. Bard, Inc. Headquartered in Taiwan, Champ Medics focuses on business development and regional country wide marketing via a network of clinical support staff and experienced sales executives.
About ETView Medical, Ltd.
ETView Medical, Ltd. (TASE: ETVW.TA ) has successfully combined airway management with continuous direct airway visualization for medical professionals. ETView's patented VivaSight™- SL, a single-use disposable medical device, consisting of a single lumen ventilation tube with an integrated continuous high resolution video imaging system, is currently sold in Europe, Israel, and the US to overcome current limitations and associated adverse surgical events during lung isolation surgeries.2 It is estimated that over 1.9 million lung isolation procedures are conducted worldwide annually,3 accounting for over $250mm in single-use medical disposables.4
The Company estimations in this press release, including those estimations regarding the Company's predicted scope of business, constitute forward-looking statements, as such term is defined under the Israeli Securities Law (5728-1968), and there is no certainty that such estimations shall materialize. The Company's estimations are based on business assumptions, prior experience, and professional data. Due to various factors, foreseen and unforeseen, including, but not limited to, changes in market trends, competition, global or local economic conditions, and amendments of regulation, such estimations may not materialize in whole or in part, or materialize in a substantially different manner than anticipated by the Company.
1 Patent Pending
2 Anesthesiology. 2006;105:471-477.
3 National Health Statistics Reports Number 29, October 26, 2010
4 Company estimates on file
Source: ETView Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.